Crossmark

Efficacy and Tolerability of Peritendinous Hyaluronic Acid in Patients with Supraspinatus Tendinopathy: a Multicenter, Randomized, Controlled Trial

Crossref DOI link: https://doi.org/10.1186/s40798-017-0089-9

Published Online: 2017-06-05

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Flores, César

Balius, Ramón

Álvarez, Guillermo

Buil, Miguel A.

Varela, Luisa

Cano, Carlos

Casariego, Joaquín
Funding

Funding for this research was provided by:

OPKO Health Spain S.L.U.
License Information

License valid from 2017-06-05